CIK 0000842023 · Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411427402
- Phone
- 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-15 | Herr Amy E. Director | Option exercise · Restricted Stock Units | −118 | 0 | ||
| 2026-08-15 | Herr Amy E. Director | Option exercise · Restricted Stock Units | −160 | 160 | ||
| 2026-08-15 | Herr Amy E. Director | Option exercise · Restricted Stock Units | −311 | 621 | ||
| 2026-07-29 | Hippel James CFO | Option exercise | +62,068 | $47.60 | $3.0M | 215,738 |
| 2026-07-29 | Hippel James CFO | Shares withheld for taxes | −51,024 | $72.03 | $3.7M | 164,714 |
| 2026-07-29 | Hippel James CFO | Option exercise · Stock Options (Right to Buy) | −62,068 | 0 | ||
| 2026-07-28 | Kelderman Kim Chief Executive Officer | Option exercise | +35,000 | $47.60 | $1.7M | 100,799 |
| 2026-07-28 | Kelderman Kim Chief Executive Officer | Shares withheld for taxes | −28,686 | $72.07 | $2.1M | 72,113 |
| 2026-07-28 | Kelderman Kim Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −35,000 | 0 | ||
| 2026-07-23 | Bohnen Shane SVP - General Counsel | Option exercise | +448 | $47.60 | $21K | 7,697 |
| 2026-07-23 | Bohnen Shane SVP - General Counsel | Shares withheld for taxes | −344 | $71.77 | $25K | 7,353 |
| 2026-07-23 | Bohnen Shane SVP - General Counsel | Option exercise · Stock Option (Right to Buy) | −448 | 0 | ||
| 2026-06-02 | Crouse Steven C. President - Diag & Spatial Bi | Option exercise | +600 | 6,977 | ||
| 2026-06-02 | Crouse Steven C. President - Diag & Spatial Bi | Shares withheld for taxes | −216 | $49.77 | $11K | 6,761 |
| 2026-06-02 | Crouse Steven C. President - Diag & Spatial Bi | Option exercise · Restricted Stock Units | −600 | 1,200 | ||
| 2026-05-08 | Herr Amy E. Director | Option exercise | +6,636 | $47.60 | $316K | 6,836 |
| 2026-05-08 | Herr Amy E. Director | Sale | −6,636 | $48.28 | $320K | 200 |
| 2026-05-08 | Herr Amy E. Director | Option exercise · Stock Option (Right to Buy) | −6,636 | 0 | ||
| 2026-05-05 | Hippel James CFO | Option exercise | +62,000 | $47.60 | $3.0M | 210,625 |
| 2026-05-05 | Hippel James CFO | Shares withheld for taxes | −56,955 | $56.68 | $3.2M | 153,670 |
Page 6 of 32 · 626 trades